Globalize the Definition, Localize the Treatment: Increasing Equity and Embracing Heterogeneity on the Road to Precision Medicine for Acute Respiratory Distress Syndrome*

1 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY. 2 Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY. 3 Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada. 4 Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada. 5 Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. *See also p. 92. Dr. Cummings' institution received funding from the National Institute of Allergy and Infectious Diseases; he received support for article research from the National Institutes of Health (K23AI163364). Dr. Fan reports personal fees from ALung Technologies, Baxter, Getinge, Inspira, Vasomune, and Zoll Medical outside the submitted work.